1. Effect of remote ischaemic preconditioning on mortality and morbidity after non-cardiac surgery:meta-analysis
- Author
-
Ismail Gögenur, Ellen Bjerrum, Jakob Burcharth, Kirsten L Wahlstrøm, and Sarah Ekeloef
- Subjects
medicine.medical_specialty ,AcademicSubjects/MED00910 ,MEDLINE ,030204 cardiovascular system & hematology ,Adaptive Immunity ,03 medical and health sciences ,0302 clinical medicine ,Postoperative Complications ,030202 anesthesiology ,Internal medicine ,Cause of Death ,Medicine ,Humans ,Ischemic Preconditioning ,Inflammation ,business.industry ,Acute kidney injury ,General Medicine ,Odds ratio ,Acute Kidney Injury ,medicine.disease ,Oxidative Stress ,Cardiovascular Diseases ,Non cardiac surgery ,Meta-analysis ,Surgical Procedures, Operative ,Orthopedic surgery ,Ischemic preconditioning ,Systematic Review ,business ,AcademicSubjects/MED00010 ,Reperfusion injury ,Biomarkers - Abstract
Background Remote ischaemic preconditioning (RIPC) has been shown to have a protective role on vital organs exposed to reperfusion injury. The aim of this systematic review was to evaluate the effects of non-invasive RIPC on clinical and biochemical outcomes in patients undergoing non-cardiac surgery Methods A systematic literature search of PubMed, EMBASE, Scopus, and Cochrane databases was carried out in February 2020. RCTs investigating the effect of non-invasive RIPC in adults undergoing non-cardiac surgery were included. Meta-analyses and trial sequential analyses (TSAs) were performed on cardiovascular events, acute kidney injury, and short- and long-term mortality. Results Some 43 RCTs including 3660 patients were included. The surgical areas comprised orthopaedic, vascular, abdominal, pulmonary, neurological, and urological surgery. Meta-analysis showed RIPC to be associated with fewer cardiovascular events in non-cardiac surgery (13 trials, 1968 patients, 421 events; odds ratio (OR) 0.68, 95 per cent c.i. 0.47 to 0.96; P = 0.03). Meta-analyses of the effect of RIPC on acute kidney injury (12 trials, 1208 patients, 211 events; OR 1.14, 0.78 to 1.69; P = 0.50; I2 = 9 per cent), short-term mortality (7 trials, 1239 patients, 65 events; OR 0.65, 0.37 to 1.12; P = 0.12; I2 = 0 per cent), and long-term mortality (4 trials, 1167 patients, 9 events; OR 0.67, 0.18 to 2.55; P = 0.56; I2 = 0 per cent) showed no significant differences for RIPC compared with standard perioperative care in non-cardiac surgery. However, TSAs showed that the required information sizes have not yet been reached. Conclusion Application of RIPC to non-cardiac surgery might reduce cardiovascular events, but not acute kidney injury or all-cause mortality, but currently available data are inadequate to confirm or reject an assumed intervention effect., This systematic review including meta-analyses and trial sequential analyses evaluated the orthopaedic effects of non-invasive remote ischaemic preconditioning on clinical and biochemical outcomes in patients undergoing non-cardiac surgery. Only RCTs were included. potential benefits remain unclear
- Published
- 2021
- Full Text
- View/download PDF